Onconetix (ONCO) EPS (Basic) (QoQ) (2021 - 2026)
Onconetix (ONCO) EPS (Basic) (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Onconetix | 1.45 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 98.09% |
| Mar 31, 2026 | -122.18% |
| Dec 31, 2025 | 196.75% |
| Sep 30, 2025 | -31.35% |
| Jun 30, 2025 | 89.53% |
| Mar 31, 2025 | 95.05% |
| Dec 31, 2024 | -268.09% |
| Sep 30, 2024 | 88.58% |
| Jun 30, 2024 | -27.69% |
| Mar 31, 2024 | 61.35% |
| Dec 31, 2023 | -326.29% |
| Sep 30, 2023 | 28.92% |
| Jun 30, 2023 | -141.17% |
| Mar 31, 2023 | 32.24% |
| Dec 31, 2022 | 2.91% |
| Sep 30, 2022 | 23.36% |
| Jun 30, 2022 | -2.56% |
| Mar 31, 2022 | 18.63% |
| Dec 31, 2021 | -6.65% |
| Sep 30, 2021 | -37.66% |